These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18228109)

  • 101. What are the best first-line antihypertensives: answers and more questions from the ALLHAT study.
    Salam AM
    Expert Opin Investig Drugs; 2003 May; 12(5):879-85. PubMed ID: 12720498
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study.
    Ma W; Sun N; Duan C; Zhao L; Hua Q; Sun Y; Dang A; Gao P; Qu P; Cui W; Zhao L; Dong Y; Cui L; Qi X; Jiang Y; Xie J; Li J; Wu G; Du X; Huo Y; Chen P;
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):41-50. PubMed ID: 32915349
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?
    Grimm RH; Davis BR; Piller LB; Cutler JA; Margolis KL; Barzilay J; Dart RA; Graumlich JF; Murden RA; Randall OS;
    J Clin Hypertens (Greenwich); 2009 Sep; 11(9):466-74. PubMed ID: 19751458
    [TBL] [Abstract][Full Text] [Related]  

  • 105. ALLHAT: still providing correct answers after 7 years.
    Einhorn PT; Davis BR; Wright JT; Rahman M; Whelton PK; Pressel SL;
    Curr Opin Cardiol; 2010 Jul; 25(4):355-65. PubMed ID: 20520537
    [TBL] [Abstract][Full Text] [Related]  

  • 106. ALLHAT--all hit or all miss? Key questions still remain.
    Messerli FH; Weber MA
    Am J Cardiol; 2003 Aug; 92(3):280-1. PubMed ID: 12888131
    [No Abstract]   [Full Text] [Related]  

  • 107. High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial.
    Schwartz JS; Wang YR; Cleland JG; Gao L; Weiner M; Poole-Wilson PA;
    Am J Manag Care; 2003 Jun; 9(6):417-24. PubMed ID: 12816171
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended.
    Du XL; Simpson LM; Tandy BC; Bettencourt J; Davis BR
    Int J Hypertens; 2021; 2021():2261144. PubMed ID: 34925915
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
    Piller LB; Baraniuk S; Simpson LM; Cushman WC; Massie BM; Einhorn PT; Oparil S; Ford CE; Graumlich JF; Dart RA; Parish DC; Retta TM; Cuyjet AB; Jafri SZ; Furberg CD; Saklayen MG; Thadani U; Probstfield JL; Davis BR;
    Circulation; 2011 Oct; 124(17):1811-8. PubMed ID: 21969009
    [TBL] [Abstract][Full Text] [Related]  

  • 110. EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.
    Babinets LS; Levchuk RD; Halabitska IM; Kryskiv OI
    Wiad Lek; 2022; 75(10):2407-2411. PubMed ID: 36472269
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Diuretic therapy in Afrocaribbeans with uncomplicated essential hypertension.
    Ester A; Teuben E; Nossent JC
    Neth J Med; 2000 Aug; 57(2):68-9. PubMed ID: 10924944
    [No Abstract]   [Full Text] [Related]  

  • 112. Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up.
    Du XL; Simpson LM; Osani MC; Yama JM; Davis BR
    J Alzheimers Dis Parkinsonism; 2022; 12(3):. PubMed ID: 35571234
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Antihypertensive medicine use differs between Ghana and Nigeria.
    Hollingworth SA; Ankrah D; Uzochukwu BSC; Okeke CC; Ruiz F; Thacher E
    BMC Cardiovasc Disord; 2022 Aug; 22(1):368. PubMed ID: 35948937
    [TBL] [Abstract][Full Text] [Related]  

  • 114. ALLHAT: is the final answer in?
    Sica DA
    Heart Dis; 2003; 5(3):171-5. PubMed ID: 12783629
    [No Abstract]   [Full Text] [Related]  

  • 115. Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.
    Jalal S; Sofi FA; Abass SM; Alai MS; Bhat MA; Rather HA; Lone NA; Siddiqi MA
    Indian J Nephrol; 2010 Jan; 20(1):15-20. PubMed ID: 20535265
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Should chlorthalidone be the diuretic of choice for antihypertensive therapy?
    Taler SJ
    Curr Hypertens Rep; 2008 Aug; 10(4):293-7. PubMed ID: 18625158
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Chlorthalidone: mechanisms of action and effect on cardiovascular events.
    Roush GC; Buddharaju V; Ernst ME; Holford TR
    Curr Hypertens Rep; 2013 Oct; 15(5):514-21. PubMed ID: 23839110
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.
    Tanner RM; Lynch AI; Brophy VH; Eckfeldt JH; Davis BR; Ford CE; Boerwinkle E; Arnett DK
    PLoS One; 2011; 6(8):e23609. PubMed ID: 21887284
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Muntner P; Levitan EB; Lynch AI; Simpson LM; Whittle J; Davis BR; Kostis JB; Whelton PK; Oparil S
    J Clin Hypertens (Greenwich); 2014 May; 16(5):323-30. PubMed ID: 24739073
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
    Bangalore S; Davis BR; Cushman WC; Pressel SL; Muntner PM; Calhoun DA; Kostis JB; Whelton PK; Probstfield JL; Rahman M; Black HR;
    Am J Med; 2017 Apr; 130(4):439-448.e9. PubMed ID: 27984005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.